CareFusion Corp. CEO Unloads $1,026,250 in Stock (CFN)
CareFusion Corp. (NYSE:CFN) CEO Kieran Gallahue sold 25,000 shares of CareFusion Corp. stock on the open market in a transaction dated Thursday, January 9th. The shares were sold at an average price of $41.05, for a total value of $1,026,250.00. Following the sale, the chief executive officer now directly owns 122,873 shares in the company, valued at approximately $5,043,937. The sale was disclosed in a filing with the SEC, which is available at this link.
CFN has been the subject of a number of recent research reports. Analysts at Zacks reiterated a “neutral” rating on shares of CareFusion Corp. in a research note to investors on Tuesday, December 24th. They now have a $42.00 price target on the stock. Separately, analysts at Bank of America Corp. reiterated a “buy” rating on shares of CareFusion Corp. in a research note to investors on Wednesday, December 18th. They now have a $45.00 price target on the stock, up previously from $43.00. Finally, analysts at Goldman Sachs Group Inc. downgraded shares of CareFusion Corp. from a “neutral” rating to a “sell” rating in a research note to investors on Tuesday, December 17th. They now have a $36.00 price target on the stock, up previously from $35.00. One analyst has rated the stock with a sell rating, five have assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $40.82.
Shares of CareFusion Corp. (NYSE:CFN) traded down 0.07% on Friday, hitting $41.22. The stock had a trading volume of 1,772,170 shares. CareFusion Corp. has a 1-year low of $29.33 and a 1-year high of $41.26. The stock’s 50-day moving average is $39.55 and its 200-day moving average is $38.13. The company has a market cap of $8.711 billion and a price-to-earnings ratio of 24.15.
CareFusion Corp. (NYSE:CFN) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.44 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.39 by $0.05. The company had revenue of $830.00 million for the quarter, compared to the consensus estimate of $818.34 million. During the same quarter in the prior year, the company posted $0.44 earnings per share. The company’s quarterly revenue was down .8% on a year-over-year basis. On average, analysts predict that CareFusion Corp. will post $2.34 earnings per share for the current fiscal year.
CareFusion Corporation (NYSE:CFN) is a global medical technology company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.